Skip to main content

Search from vocabulary

Content language

Concept information

Pharmaceutical Preparations > Drug Combinations > Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
... > Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Azoles > Imidazoles > Olmesartan Medoxomil > Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
... > Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Azoles > Tetrazoles > Olmesartan Medoxomil > Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
... > Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyridines > Dihydropyridines > Amlodipine > Amlodipine Besylate, Olmesartan Medoxomil Drug Combination

Preferred term

Amlodipine Besylate, Olmesartan Medoxomil Drug Combination  

Type

  • Topical Descriptor

Entry terms

  • Amlodipine Besylate Olmesartan Medoxomil
  • Amlodipine Besylate, Olmesartan Medoxomil
  • Amlodipine Besylate-Olmesartan Medoxomil
  • Amlodipine Besylate Olmesartan Medoxomil Drug Combination
  • Amlodipine Besylate-Olmesartan Medoxomil Drug Combination
  • Besylate-Olmesartan Medoxomil, Amlodipine
  • Medoxomil, Amlodipine Besylate-Olmesartan

Scope note

  • A pharmaceutical preparation of amlodipine besylate and olmesartan medoxomil that combines ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST and CALCIUM CHANNEL BLOCKER activities. It is used in the management of HYPERTENSION.

History note

  • 2016

In other languages

URI

http://www.yso.fi/onto/mesh/D000068558

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/1/15, last modified 5/27/16